Chronic kidney disease

AC Webster, EV Nagler, RL Morton, P Masson - The lancet, 2017 - thelancet.com
The definition and classification of chronic kidney disease (CKD) have evolved over time,
but current international guidelines define this condition as decreased kidney function …

[HTML][HTML] Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment

IH de Boer, ML Caramori, JCN Chan, HJL Heerspink… - Kidney international, 2020 - Elsevier
The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for
Diabetes Management in Chronic Kidney Disease represents the first KDIGO guideline on …

KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease

IH de Boer, ML Caramori, JCN Chan… - Kidney …, 2020 - kidney-international.org
This is an opportune time to publish the first KDIGO 2020 Clinical Practice Guideline for
Diabetes Management in Chronic Kidney Disease (CKD). Worldwide, the estimated number …

[PDF][PDF] ISPAD clinical practice consensus guidelines 2022: microvascular and macrovascular complications in children and adolescents with diabetes

P Bjornstad, A Dart, KC Donaghue, A Dost… - 2022 - deepblue.lib.umich.edu
The long-term vascular complications of diabetes include diabetic kidney disease (DKD),
retinopathy, neuropathy, and macrovascular disease. The outcomes are:• kidney failure and …

KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease

AK Cheung, TI Chang, WC Cushman… - Kidney …, 2021 - kidney-international.org
The original KDIGO Clinical Practice Guideline for the Management of Blood Pressure in
Chronic Kidney Disease in the chronic kidney disease (CKD) population not receiving …

ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents

KC Donaghue, ML Marcovecchio… - Pediatric …, 2018 - pmc.ncbi.nlm.nih.gov
The long-term vascular complications of diabetes include nephropathy, retinopathy,
neuropathy, and macrovascular disease. The outcomes are:• renal failure and hypertension …

Diabetes management in chronic kidney disease: synopsis of the 2020 KDIGO clinical practice guideline

SD Navaneethan, S Zoungas, ML Caramori… - Annals of internal …, 2021 - acpjournals.org
Description: The Kidney Disease: Improving Global Outcomes (KDIGO) organization
developed a clinical practice guideline in 2020 for the management of patients with diabetes …

KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease

P Rossing, ML Caramori, JCN Chan… - Kidney …, 2022 - kidney-international.org
The KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney
Disease (CKD) follows only 2 years after the original KDIGO 2020 Clinical Practice …

CKD in China: evolving spectrum and public health implications

C Yang, H Wang, X Zhao, K Matsushita… - American Journal of …, 2020 - Elsevier
Diabetes is the leading cause of kidney failure worldwide, whereas glomerulonephritis has
been predominant in develo** countries such as China. The prevalence of obesity and …

How to prevent the microvascular complications of type 2 diabetes beyond glucose control

WM Valencia, H Florez - Bmj, 2017 - bmj.com
Microvascular complications (retinopathy, nephropathy, and neuropathy) affect hundreds of
millions of patients with type 2 diabetes. They usually affect people with longstanding or …